Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Profit After Tax: 2023-2024

Historic Profit After Tax for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to -$16.1 million.

  • Artiva Biotherapeutics' Profit After Tax fell 34.15% to -$16.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$65.4 million, marking a year-over-year change of. This contributed to the annual value of -$65.4 million for FY2024, which is 127.62% down from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Profit After Tax of -$16.1 million as of Q4 2024, which was up 7.88% from -$17.5 million recorded in Q3 2024.
  • Over the past 5 years, Artiva Biotherapeutics' Profit After Tax peaked at $11.3 million during Q3 2023, and registered a low of -$17.8 million during Q2 2024.
  • Moreover, its 2-year median value for Profit After Tax was -$16.1 million (2024), whereas its average is -$11.8 million.
  • Data for Artiva Biotherapeutics' Profit After Tax shows a maximum YoY crashed of 254.91% (in 2024) over the last 5 years.
  • Over the past 2 years, Artiva Biotherapeutics' Profit After Tax (Quarterly) stood at -$12.0 million in 2023, then plummeted by 34.15% to -$16.1 million in 2024.
  • Its last three reported values are -$16.1 million in Q4 2024, -$17.5 million for Q3 2024, and -$17.8 million during Q2 2024.